Health Care/Hospital APAC News & Press Release Distribution

Health Care/Hospital

All
Global

Biocon Biologics Symposium on '100 Years of Insulin - Delivering on Universal Access & Equitable Care' Resonates Well With Leading KOLs at IDF Congress 2019

BENGALURU, India, Dec. 12, 2019 /PRNewswire/ -- Biocon Biologics, a fully integrated 'pure play' global biosimilars organisation, brought together Key Opinion Leaders (KOLs), including physicians, scientists, healthcare professionals, government representatives, policy makers, and IDF members, at...

2019-12-12 09:00 1692

Human Microbiome Market to Reach $6.08 Billion by 2023, Powered by the High Growth in Over-the-Counter Probiotics

SANTA CLARA, California, Dec. 11, 2019 /PRNewswire/ -- There has been a surge in industry-academia collaborations in thehuman microbiome therapeutics space. The partnerships betweenpharma/biotech companies and academic institutes are bringing together the research expertise of educational organiz...

2019-12-11 23:55 954

Human Microbiome Market to Reach $6.08 Billion by 2023, Powered by the High Growth in Over-the-Counter Probiotics

SoClean Continues Global Expansion with Appointment of Francis Choi as Vice President of Asia-Pacific Market

Former Vice President of Strategy & Business Development, Enterprise Solutions for Siemens Healthineers Greater China Joins SoClean PETERBOROUGH, N. H., Dec. 11, 2019 /PRNewswire/ -- SoClean, the creator of SoClean 2, announced today that it has engagedFrancis Choi as its Vice President ofAsia P...

2019-12-11 21:01 2013

Tenth Record-Breaking Year in a Row for ZEISS

STUTTGART, Germany, Dec. 11, 2019 /PRNewswire/ -- The ZEISS Group continued its growth trajectory, with revenue and earnings reaching new heights in fiscal year 2018/19, which ended30 September 2019. Revenue grew by 11 percent, reaching 6.428 billion euros (previous year: 5.817 billion euros). Adj...

2019-12-11 20:59 2357

GemVax announced phase II results of GV1001 for Alzheimer's disease treatment at CTAD 2019

SEOUL, South Korea, Dec. 11, 2019 /PRNewswire/ -- The 12th Clinical Trials on Alzheimer's Disease (CTAD) 2019 was held inSan Diego, USA, from December 4-7. At the CTAD, the results of various Alzheimer's disease clinical trials were shared, and it provided a glimpse into the possibility of treati...

2019-12-11 18:40 1404

Xinhua Silk Road: E. China Nanjing Jiangbei New Area aims to develop life and health industry

BEIJING, Dec. 11, 2019 /PRNewswire/ -- Nanjing Jiangbei New Area, a state-level new area in East China'sJiangsu Province, is committed to building a 100 billion-yuan level life and health industrial cluster and becoming a gene city inChina. The news was announced by Luo Qun, a member of the Stan...

2019-12-11 16:52 3347

Xinhua Silk Road: E. China Nanjing Jiangbei New Area aims to develop life and health industry

West China Hospital to build new hospital in Chengdu Tianfu New Area

CHENGDU, China, Dec. 11, 2019 /PRNewswire/ -- West China Hospital of Sichuan University, a prestigious medical center located inChengdu, Sichuan province, signed an agreement on Dec. 5 with the Chengdu Management Committee of Tianfu New Area, China's 11th national-level development area, to build...

2019-12-11 13:47 3134

West China Hospital to build new hospital in Chengdu Tianfu New Area

CStone announces enrollment target reached in the global Phase III VOYAGER trial of avapritinib in Chinese patients with third-line GIST

SUZHOU, China, Dec. 11, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced that the on-going, global Phase III VOYAGER clinical trial of avapritinib, an investigational drug discovered by CStone's partner, Blueprint Medicines, has completed target ...

2019-12-11 11:00 2941

AGC Biologics Expands Plasmid DNA Offering

SEATTLE, Dec. 11, 2019 /PRNewswire/ -- AGC Biologics, a global Contract Development and Manufacturing Organization (CDMO) for Biopharmaceuticals, is significantly expanding its CDMO services with plasmid DNA (pDNA) offerings from itsHeidelberg site in Germany. With the demand for pDNA growing rap...

2019-12-11 09:06 2203

Kazia Initiates Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma

SYDNEY, Dec. 11, 2019 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it's lead program, GDC-0084, has been selected to join GBM AGILE, an international, academic-led, multi-drug adaptive phase ...

2019-12-11 08:41 6508

Ascentage Pharma Releases Updated Data of its Novel BCR-ABL Inhibitor, HQP1351, in an Oral Presentation Nominated for "Best of ASH"

SUZHOU, China and ROCKVILLE, Md., Dec. 11, 2019 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the updated results ...

2019-12-11 08:00 12346

1 ... 569 570 571 572573